The Veda board announced to the Australian Securities Exchange today that that it had unanimously recommended acceptance of the acquisition offer made by Equifax in October, stating that the the offer price of $2.825 per share is a higher price than the company has traded at since it listed in December, 2013.
Commenting on the transaction, Veda chairman, Dr Helen Nugent said the board had concluded the sale of the company at a significant premium to market was an attractive outcome for shareholders.
Veda has carved out a strong market position servicing the Australian financial services industry with an increasing presence in providing data analytics to the superannuation sector.




